Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

954 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.
Visram A, Rajkumar SV, Kapoor P, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Dingli D, Kourelis T, Gonsalves W, Warsame R, Muchtar E, Leung N, Kyle RA, Kumar SK. Visram A, et al. Among authors: gertz ma. Leukemia. 2024 Aug;38(8):1862. doi: 10.1038/s41375-024-02306-7. Leukemia. 2024. PMID: 38956316 No abstract available.
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A, Kyle R, Merlini G, Miguel JS, Ludwig H, Hajek R, Palumbo A, Jagannath S, Blade J, Lonial S, Dimopoulos M, Comenzo R, Einsele H, Barlogie B, Anderson K, Gertz M, Harousseau JL, Attal M, Tosi P, Sonneveld P, Boccadoro M, Morgan G, Richardson P, Sezer O, Mateos MV, Cavo M, Joshua D, Turesson I, Chen W, Shimizu K, Powles R, Rajkumar SV, Durie BG; International Myeloma Working Group. Dispenzieri A, et al. Leukemia. 2009 Feb;23(2):215-24. doi: 10.1038/leu.2008.307. Epub 2008 Nov 20. Leukemia. 2009. PMID: 19020545 Review.
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
Terpos E, Dimopoulos MA, Sezer O, Roodman D, Abildgaard N, Vescio R, Tosi P, Garcia-Sanz R, Davies F, Chanan-Khan A, Palumbo A, Sonneveld P, Drake MT, Harousseau JL, Anderson KC, Durie BG; International Myeloma Working Group. Terpos E, et al. Leukemia. 2010 Oct;24(10):1700-12. doi: 10.1038/leu.2010.173. Epub 2010 Sep 2. Leukemia. 2010. PMID: 20811404 Free article. Review.
Cumulative Deficits Frailty Index and Relationship Status Predict Survival in Multiple Myeloma.
Abdallah N, Dizona P, Kumar A, LaPlant B, Menser T, Schaeferle G, Aug S, Weivoda M, Dispenzieri A, Buadi FK, Warsame R, Cook J, Lacy MQ, Hayman SR, Gertz MA, Rajkumar SV, Kumar SK. Abdallah N, et al. Among authors: gertz ma. Blood Adv. 2024 Dec 18:bloodadvances.2024014624. doi: 10.1182/bloodadvances.2024014624. Online ahead of print. Blood Adv. 2024. PMID: 39693516
Prognostic Impact of Patient-Reported Symptoms in Multiple Myeloma.
Abdallah N, Bohra A, Mammadzadeh A, Buadi FK, Kapoor P, Dispenzieri A, Gertz MA, Hayman SR, ElHaj M, Dingli D, Cook J, Binder M, Lin Y, Kourelis TV, Warsame R, Thompson CA, Menser T, Rajkumar SV, Kumar SK. Abdallah N, et al. Among authors: gertz ma. Blood Adv. 2024 Dec 5:bloodadvances.2024014232. doi: 10.1182/bloodadvances.2024014232. Online ahead of print. Blood Adv. 2024. PMID: 39637309
Retreatment of multiple myeloma with previously refractory drugs.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder A, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame RM, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: gertz ma. Blood Adv. 2024 Dec 24;8(24):6321-6328. doi: 10.1182/bloodadvances.2024014723. Blood Adv. 2024. PMID: 39536293
FDA IDE validation of multiple myeloma MRD test by flow cytometry.
Jevremovic D, Shi M, Horna P, Otteson GE, Timm MM, Bennett SA, Baughn LB, Greipp PT, Gonsalves WI, Kapoor P, Gertz MA, Binder M, Buadi FK, Dispenzieri A, Kourelis T, Muchtar E, Zhou J, Rajkumar SV, Kumar SK, Olteanu H. Jevremovic D, et al. Among authors: gertz ma. Am J Hematol. 2024 Dec;99(12):2399-2401. doi: 10.1002/ajh.27484. Epub 2024 Sep 18. Am J Hematol. 2024. PMID: 39291868 No abstract available.
Evaluating early intervention in smoldering myeloma clinical trials: a systematic review.
Kakkilaya A, Trando A, Cliff ERS, Mian H, Al Hadidi S, Aziz M, Goodman AM, Jeong AR, Smith WL, Kelkar AH, Russler-Germain DA, Mehra N, Chakraborty R, Gertz MA, Mohyuddin GR. Kakkilaya A, et al. Among authors: gertz ma. Oncologist. 2024 Sep 5:oyae219. doi: 10.1093/oncolo/oyae219. Online ahead of print. Oncologist. 2024. PMID: 39236068 Free article.
954 results